NEWS Breaking News FDA Approves First MSC Therapy for SR-aGVHD: A Milestone in Cell Therapy Read More » January 4, 2025 No Comments Breaking News Launch of DestroCell in Tehran Marks a New Era in Cell Therapy for Iran and Beyond Read More » November 10, 2024 No Comments Breaking News Taskin Bioregeneration Announces Launch of Phase II/III Clinical Trials for DesRep Read More » October 13, 2024 No Comments Breaking News Job Opportunity – Researcher Positions at Taskin Bioregeneration Read More » October 13, 2024 No Comments Breaking News DestroCell Offers New Hope for Steroid-Resistant GVHD Treatment Read More » September 15, 2024 No Comments
Breaking News FDA Approves First MSC Therapy for SR-aGVHD: A Milestone in Cell Therapy Read More » January 4, 2025 No Comments
Breaking News Launch of DestroCell in Tehran Marks a New Era in Cell Therapy for Iran and Beyond Read More » November 10, 2024 No Comments
Breaking News Taskin Bioregeneration Announces Launch of Phase II/III Clinical Trials for DesRep Read More » October 13, 2024 No Comments
Breaking News Job Opportunity – Researcher Positions at Taskin Bioregeneration Read More » October 13, 2024 No Comments
Breaking News DestroCell Offers New Hope for Steroid-Resistant GVHD Treatment Read More » September 15, 2024 No Comments